Refine by
Radiation Oncology Articles & Analysis
45 news found
It has the potential to revolutionize radiation oncology, having demonstrated compelling success in some of the most difficult-to-treat cancers and in treating patients for whom all other treatment options have been exhausted. ...
It has the potential to revolutionize radiation oncology, having demonstrated compelling success in some of the most difficult-to-treat cancers and in treating patients for whom all other treatment options have been exhausted. ...
“Our research shows that radiation oncologists and patients cite SOM as the most burdensome radiotherapy toxicity in head and neck cancer treatment, and there are currently no FDA-approved drugs to reduce the incidence or duration of SOM in solid tumors. ...
” Proton therapy, a highly advanced form of radiation therapy, targets tumors with greater precision than traditional x-ray-based radiotherapy and can reduce the amount of unnecessary radiation exposure to vulnerable healthy tissue and organs. ...
BURLINGTON, Mass. and OXFORD, UK, October 19, 2021 - Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of innovative PET radiopharmaceuticals, today announced presentations on Axumin® (fluciclovine F 18) and 18F-fluciclovine at the upcoming American Society for Radiation Oncology (ASTRO) 2021 Annual ...
For the first time, there is a personalized medicine tool that identifies which patients benefit from RT and discriminates between patients who have a low or elevated risk of recurrence after lumpectomy and RT,” said Rachel Rabinovitch, MD, Professor, Radiation Oncology, University of Colorado. “We are pleased to share our latest data demonstrating ...
Lustig, M.D., Professor of Clinical Radiation Oncology and Director of Clinical Operations, Radiation Oncology at Penn Medicine; Chad Tang, M.D., Assistant Professor, Department of Radiation Oncology, University of Texas MD Anderson Cancer Center; Cullen M. ...
ByCervoMed
RTsafe is happy to announce that its PRIME and Pseudopatient 3D phantoms, have been selected by a consortium of high-end German Radiotherapy Institutions – led by the Division of Medical Physics of the Department of Radiation Oncology at the Medical Center of University of Freiburg – towards supporting a study whose results will be used for the ...
ByRTsafe
Chirag Shah, Director of Breast Radiation Oncology and Director of Clinical Research in the Department of Radiation Oncology at Cleveland Clinic and co-investigator of the PREVENT Trial. ...
Drs. Ondrej Choutka, MD, a neurosurgeon, and Lindsay Sales, MD, a radiation oncologist at Saint Alphonsus Regional Medical Center in Boise, have become the first doctors in the Pacific Northwest to utilize a new treatment for brain tumors. They implanted the FDA-cleared GammaTile therapy in a 44-year-old patient with a malignant brain tumor. The current standard of care for patients with ...
Corrected topline Phase 3 ROMAN data demonstrate primary endpoint achieved statistical significance in reducing the incidence of radiotherapy-induced severe oral mucositis (p=0.045) Topline results from single-arm Phase 2a trial of avasopasem in Europe in line with the ROMAN trial results Company plans to discuss avasopasem data with the FDA in 2022 Company to host conference call and live ...
The randomized study demonstrates that the DCISionRT test predicts radiation benefit for reducing 10-year local invasive breast cancer risk. ...
This endeavour will be referred to as ‘The Kaplan Project’ in honor of Stanford’s former radiation oncology leader, Dr. Henry Kaplan, who in the 1960s developed some of the earliest treatments for lymphoma. ...
Since moving to Melbourne from West Virginia over 30 years ago, O'Neal has forged a successful career as a lawyer, and in 2013 became the first-ever female president of an AFL club. O'Neal is also a board member of Women’s Housing Ltd – helping disadvantaged and vulnerable women gain access to safe housing. Previous Melburnian of the Year winners include leading medical ...
Conducted by a joint team of breast surgeons and radiation oncologists at Brown University and Tufts Medical Center, the analysis compared the repeatable delineation of the tumor bed after lumpectomy for radiation therapy planning and treatment as well as safety and effectiveness. ...
Lord Mayor Sally Capp said 2021’s finalists have gone above and beyond to make our city better. “We’re thrilled to recognise and celebrate the inspirational people who are making invaluable contributions to our city,” the Lord Mayor said. “It’s the people that make our city the wonderful place it is, and the Melbourne Awards finalists are a testament to our ...
Proton therapy is a precise form of radiation therapy that can reduce the amount of unnecessary radiation exposure to healthy tissue, which has the potential to reduce side effects, escalate dose, and lessen the risk of secondary malignancies. ...
TAE Life Sciences (TLS), a biological-targeted radiation therapy company developing next-generation boron neutron capture therapy (BNCT), today announced the sponsorship of an Industry-Expert Theater session focused on advancements in BNCT at the American Society for Radiation Oncology (ASTRO) Annual Meeting, occurring October 24-27, 2021. The ...
Clinical update and translational data from SPEARHEAD-1 in patients with synovial sarcoma and MRCLS to be presented at CTOS The Company will host its first virtual medical symposium at CTOS Translational data from Phase 1 SURPASS trial to be presented at SITC Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in cell therapy to treat cancer, will present clinical and translational data ...
MiraDx, in collaboration with the UCLA Jonsson Comprehensive Cancer Center, is conducting a clinical trial to validate a novel prostate cancer biomarker panel designed to help assess patients who were at a greater risk of having long-term toxicity in response to their radiation treatment, to help guide treatment decisions. Treatment can involve radiation ...
ByMiraDx